Running head of the title : Establishment of Permanent Glioma Stem Cell Lines
HUANG QIANG,ZHANG QUANBIN,DONG JUN,WU YINYAN,SHEN YUNTIAN,ZHAO YAODONG,ZHU YUDE,るDIAO YIるWANG AIDONG,LAN QING
2008-01-01
Abstract:To fully understand the biology of glioma stem cells (GSCs), it is highly desirable to establish permanent and biologically stable GSCs lines. In the current study, GSCs were isolated from the primary and recurrent gliomas in the same patient. During the long-term maintenance, cryopreservation and resuscitation of GSCs were performed periodically and their biological behaviors were investigated. As a result, GSC lines named SU-1 for the primary and SU-2 for the recurrent have been kept in vitro for more than 46 months and 40 months respectively. Generally, the potentials to proliferate, self-renew and multi-differentiate were relatively stable even after undergoing cryopreservation and resuscitation. Transplantation of SU-1 cells produced relatively less invasive intracranial tumor mass in NC nude mice, while SU-2 cells resulted in much more diffuse and aggressive lesions, both of which strikingly recapitulated their original tumors. Under differentiation-inducing conditions, both SU-1 and SU-2 exhibited impressive resistance, and their differentiation status seemed blocked at the phase of Nestin expressing as no matter how and when they were induced, most of these cells were positively stained for Nestin. Array-based comparative genomic hybridization further discovered some interesting genetic alterations, including amplification of oncogene EGFR and deletion of tumor suppressor PTEN in both SU-1 and SU-2, and particular amplification of MTA1 (metastasis associated gene 1) in SU-2. Taken together, GSCs cell lines SU-1 and SU-2 faithfully retained biological behaviors of their original tumors and provided reliable resource in investigating the mechanisms of formation and recurrence of human malignant gliomas. INTRODUCTION In the past decades, both the treatment trials and basic research concerning human glioma, the most common central nervous malignance, have made limited progress, partly due to the fact that the previously established glioma cell lines are comprised of morphologically and functionally diverse cells that express a variety of neural lineage markers ]3_0It is now generally accepted that previously established serum-based cell lines do not replicate the major biological features, particularly the stem cells, of human cancers. Therefore, new and clinically relevant in vitro model systems are highly desired to study the tumor biology and to conduct preclinical drug screening of malignant brain tumors. There is overwhelming evidence that among glioma tissue, there exist stem cells that are similar to but essentially distinguished from neural stem cells ]4/7_. As this subpopulation of glioma cells, generally called glioma stem cells (GSCs), may play an extremely critical role in initiation and recurrence of gliomas, study focusing on GSCs has been pushed forward rapidly. However, as far as biological features of GSCs are concerned, the conclusions are not always consistent and sometimes even confusing ]3."8/36_. Although most of the investigators believe that short-term cultured stem cells are superior to those in long-term growth. However, since there is a significant lack of tumor tissues, it is difficult to have tumor stem cells readily both for biological and preclinical drug studies, so permanent GSCs cell lines could serve this purpose better than short-term kept GSCs. Tumor recurrence is the primary cause of treatment failure and the death of glioma patients. Although cancer stem cells are now widely believed to be the true cells responsible for tumor recurrence, we do not know if the cancer stem cell in the recurrent tumor is exactly the same as those in the primary tumor. We have isolated GSCs from surgical specimens both of the primary and the recurrent gliomas in recent years. Fortunately, GSCs were screened out and could be mainteined for long time from the primary and recurrent tumors of one same patient" ]37_. In the current study, we described our results of long-term in vitro (more than three years) growth and detailed characterization of these GSCs. During the long-term culture, GSCs were periodically cryopreserved and tested for their capabilities of forming new neurospheres upon retrieval to make sure that GSCs are available for utilization when necessary. We also compared the capacities between the primaryand recurrent-tumor derived GSCs. MATERIAL AND METHODS Clinical Information Our study was approved by the Medical Review Board of Suzhou University Medical School. Fresh surgical specimens were obtained from a 50-year-old female patient who underwent twice operations with an interval of 6 months due to the rapid relapse of tumor mass in the right temporal lobe. In recurrence, besides the tumor regrowth in situ, a new solitary focus emerged in the ipisilateral fontal region. The primary lesion was pathologically diagnosed as mixed glioma comprised of anaplastic ependymoma and astrocytoma, while the recurrent lesion was revealed to have transformed and progressed into glioblastoma multiform (Fig. 1). Isolation and Culture of Glioma Stem Cells Tumor sphere culturing was performed as described previously with some modification ]38_. Briefly, the fresh tumor tissues were washed with PBS, then minced into small pieces mechanically and enzymetically dissociated into single cells. For magnetic labeling, CD133/1MicroBeads were used (Miltenyi Biotec). Postitive magnetic cell sorting (MACS) was carried out using several MACS columns in series according to the manufacturer’s instructions (Miltenyi Biotec). The isolated CD133 + cells were suspended in defined stem cell medium containing DMEM-F-12 (GIBCO-Invitrogen), N2 supplement (Gibco), penicillin G, streptomycin sulfate, recombinant human FGF-2 (20 ng/ml; R&D System), recombinant human EGF(20 ng/ml; R&D Systems), and plated at a density of 2×10 6 live cells per 75 cm 2 uncoated plastic flask. Subsphere Forming Assay Tumor spheres of different passages were dissociated into single cells and plated at density ranging from 20 cells to 200 cells per well. Culture medium were changed half (50⊂n+" of defined stem cell medium every 3 days till day 10. Formation of subspheres was observed under phase-contrast microscope.